Lincoln National Corp. (0JV3)
London Exchange · UK · prices in USD · close of 19 Oct 2026
Key indicators
| Last close | USD 39.38 |
|---|---|
| 52-week range | 31.12 – 47.48 |
| Return, 1 month / 3 months | −6.5% / −5.3% |
| Return, 1 year / 3 years | +4.1% / +86.2% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 39 |
| Volatility (1 year) | 33.9% |
| Worst drawdown (1 year) | -30.1% |
| Average daily value traded | 0.03M USD |
| Dividend yield | 4.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Lincoln National Corporation is an insurance holding company based in the United States that operates through subsidiaries under the Lincoln Financial Group name. It provides life insurance, annuities, retirement plan services and group protection products to individuals, employers and institutional clients. Its customers include families planning for retirement and protection needs, along with companies seeking employee benefit coverage such as disability and group life insurance.
On this site Lincoln National Corp. appears as a stock on the London Exchange (UK), code 0JV3, with prices in US dollars (USD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Lincoln National Corp. (0JV3) trades on the London Exchange in UK. It last closed at USD 39.38 on 19 October 2026.
Its price-based Market X-Ray is 51 out of 100 (a fair price profile), ranking 1,992 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 4.1% and over the last three months it fell 5.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 63 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 2.4% | ||
| From 52-week high | -15.1% | ||
| Momentum | 55 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -5.3% | ||
| 6-month return | 11.0% | ||
| 12-month return, skipping the last month | 11.4% | ||
| Stability (higher is calmer) | 50 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 33.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -30.1% | ||
| Liquidity | 20 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.03M USD | ||
| Zero-volume days | 0.0% | ||
| Income | 63 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 4.6% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −1.7% |
|---|---|
| 1 month | −6.5% |
| 3 months | −5.3% |
| 6 months | +11.0% |
| 1 year | +4.1% |
| 3 years | +86.2% |
| 5 years | – |
Signals
| 50-day / 200-day average | 42.27 / 38.44 |
|---|---|
| Golden / death cross (60 days) | Golden, 52 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.03 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 9 Oct 2026 | USD 0.4500 |
| 9 Jul 2026 | USD 0.4500 |
| 10 Apr 2026 | USD 0.4500 |
| 9 Jan 2026 | USD 0.4500 |
| 10 Oct 2025 | USD 0.4500 |
| 9 Jul 2025 | USD 0.4500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.